IMPERIAL OIL LTD (IMO)

CA4530384086 - Common Stock

47.83  -0.19 (-0.4%)

After market: 47.83 0 (0%)


Fundamental Rating

6

Overall IMO gets a fundamental rating of 6 out of 10. We evaluated IMO against 381 industry peers in the Oil, Gas & Consumable Fuels industry. While IMO has a great health rating, its profitability is only average at the moment. A decent growth rate in combination with a cheap valuation! Better keep an eye on IMO.




Profitability

Profitability Rating

6

IMO's Return On Assets of 17.61% is amongst the best of the industry. IMO does better than the industry average Return On Assets of 13.62%.
IMO has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for IMO.

IMO has a Return On Equity of 31.64%. This is comparable to the industry average of 28.96%.
IMO's Profit Margin of 12.61% is worse than the rest of the industry. The industry average Profit Margin is 28.48%.
VS Industry

ROA (17.61%) VS Industry: 61% outperformed.

0.14
2,236.96

ROE (31.64%) VS Industry: 54% outperformed.

0.15
22,783.17

Profit Margin (12.61%) VS Industry: 25% outperformed.

0.19
159.88

Valuation

Valuation Rating

7

With a Price/Earnings Ratio of 5.42, the valuation of IMO can be described as very cheap.
With a Forward Price/Earnings Ratio of 7.26, the valuation of IMO can be described as cheap.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMO's Price/Earning Ratio is in line with the industry average which is at 5.48.

With a price book ratio of 1.60, IMO is valued correctly.
Compared to an average industry Enterprise Value to EBITDA ratio of 3.65, IMO is valued in line with its industry peers.
When comparing the price book ratio of IMO to the average industry price book ratio of 1.36, IMO is valued more expensive than its industry peers.
VS Industry

Price/Earnings (5.42) VS Industry: 50% outperformed.

153.50
0.01

Price/Book (1.6) VS Industry: 39% outperformed.

4,701.10
0.04

Enterprise Value/ EBITDA (3.48) VS Industry: 52% outperformed.

235.43
0.38

Growth

Growth Rating

5

IMO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 142.54%, which is quite impressive.
Measured over the past 5 years, IMO shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.81% on average per year.
IMO shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.23%.
Measured over the past 5 years, IMO shows a quite strong growth in Revenue. The Revenue has been growing by 15.32% on average per year.

Based on estimates for the next 5 years, IMO will show a decrease in Earnings Per Share. The EPS will decrease by -5.93% on average per year.
The Revenue is expected to grow by 1.95% on average over the next 5 years.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS55.81% 78.75% 142.54% -27.22% -12.16% -5.93% N/A
Revenue15.32% 20.45% 36.23% 0.35% 1.09% 1.95% N/A

Health

Health Rating

7

IMO has an Altman-Z score of 4.17. This indicates that IMO is financially healthy and little risk of bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.07, IMO is in better financial health than the average industry peer.
The Piotroski-F score of IMO is 9.00. This is a very strong score and indicates great health and profitability for IMO.
IMO has a Current Ratio of 1.41. This is a normal value and indicates that IMO is financially healthy and should not expect problems in meeting its short term obligations.

IMO has a Current Ratio comparable to the industry average, which is at 1.12.
A Quick Ratio of 1.15 indicates that IMO should not have too much problems paying its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 0.97.
The Debt to Equity ratio of IMO is in line with the industry averages.
VS Industry

Debt/Equity (0.17) VS Industry: 55% outperformed.

13.98
0.00

Quick Ratio (1.15) VS Industry: 57% outperformed.

0.00
186.31

Current Ratio (1.41) VS Industry: 60% outperformed.

0.00
186.31

Altman-Z (4.17) VS Industry: 77% outperformed.

-509,914.51
326.97

Dividend

Dividend Rating

5

The dividend of IMO is nicely growing with an annual growth rate of 16.65%!
12.57% of the earnings are spent on dividend by IMO. This is a low number and sustainable payout ratio.
IMO has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 3.19%, IMO has a reasonable but not impressive dividend return.

IMO's Dividend Yield is comparable with the S&P500 average which is at 2.71.
IMO's Dividend Yield is slightly below the industry average, which is at 5.98.
The Dividend Rate of IMO has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (3.19%) VS Industry: 27% outperformed.

0.29
63.00

IMPERIAL OIL LTD

NYSEARCA:IMO (6/5/2023, 7:14:57 PM)

After market: 47.83 0 (0%)

47.83

-0.19 (-0.4%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-28 2023-04-28/bmo
Earnings (Next)07-27 2023-07-27/bmo
Inst Owners20.86%
Inst Owner Change-1.29%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.94B
Analysts71.43
Price Target59.06 (23.48%)
Dividend
Industry RankSector Rank
Dividend Yield 3.19%
Dividend Growth(5Y)16.65%
DP12.57%
Div Incr Years5
Div Non Decr Years5
Ex-Date06-01 2023-06-01 (0.5)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.75%
Min EPS beat(2)8.96%
Max EPS beat(2)10.54%
EPS beat(4)4
Avg EPS beat(4)19.67%
Min EPS beat(4)8.96%
Max EPS beat(4)41.39%
Revenue beat(2)N/A
Avg Revenue beat(2)-12.92%
Min Revenue beat(2)-15.4%
Max Revenue beat(2)-10.44%
Revenue beat(4)N/A
Avg Revenue beat(4)-20.15%
Min Revenue beat(4)-34.07%
Max Revenue beat(4)-10.44%
PT rev (1m)-0.92%
PT rev (3m)0.03%
EPS NQ rev (1m)-15.28%
EPS NQ rev (3m)-18.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.19%
Revenue NQ rev (1m)2.75%
Revenue NQ rev (3m)5.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.22%
Valuation
Industry RankSector Rank
PE 5.42
Fwd PE 7.26
P/S 0.64
P/FCF 6.16
P/OCF 4.85
P/B 1.6
P/tB 1.61
EV/EBITDA 3.48
EPS(TTM)8.82
EY18.44%
EPS(NY)6.59
Fwd EY13.78%
FCF(TTM)7.76
FCFY16.23%
OCF(TTM)9.87
OCFY20.63%
SpS74.91
BVpS29.85
TBVpS29.64
PEG (NY)N/A
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 17.61%
ROE 31.64%
ROIC 20.15%
ROICexc 21.51%
ROICexgc 21.61%
OM 15.94%
PM 12.61%
GM 24.56%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROICexcg growth 3Y74.42%
ROICexcg growth 5Y97.73%
ROICexc growth 3Y74.41%
ROICexc growth 5Y97.72%
OM growth 3Y37.6%
OM growth 5Y66.02%
PM growth 3Y24.06%
PM growth 5Y49%
GM growth 3Y7.7%
GM growth 5Y5.78%
F-Score9
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 0.68
Debt/EBITDA 0.37
Cap/Depr 84.19%
Profit Quality 82.21%
Current Ratio 1.41
Quick Ratio 1.15
Altman-Z 4.17
F-Score9
WACC7.49%
ROIC/WACC2.89
Cap/Depr(3y)54.34%
Cap/Depr(5y)72.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y142.54%
EPS 3Y78.75%
EPS 5Y55.81%
EPS growth Q2Q21.71%
EPS Next Y-27.22%
EPS Next 2Y-12.16%
EPS Next 3Y-5.93%
EPS Next 5YN/A
Revenue growth 1Y36.23%
Revenue growth 3Y20.45%
Revenue growth 5Y15.32%
Revenue growth Q2Q-4.74%
Revenue Next Year0.35%
Revenue Next 2Y1.09%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y120.67%
EBIT growth 3Y65.74%
EBIT growth 5Y91.46%
EBIT Next Year6.55%
EBIT Next 3Y-3.68%
EBIT Next 5YN/A
FCF growth 1Y777.12%
FCF growth 3Y47.46%
FCF growth 5Y38.3%
OCF growth 1Y445.56%
OCF growth 3Y33.26%
OCF growth 5Y30.56%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA